Gene expression signatures of mouse bone marrow-derived mesenchymal stem cells in the cutaneous environment and therapeutic implications for blistering skin disorder

Cytotherapy

Volumn 13, Issue 1, 2011, Pages 30-45

  Alexeev, Vitali ^a   Uitto, Jouni ^a   Igoucheva, Olga ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Adult stem cells; Differentiation; Gene expression analysis; Genodermatoses; Mesenchymal stromal cells; Transplantation

Indexed keywords

ACTIVIN RECEPTOR 2; ALPHA5 INTEGRIN; BETA1 INTEGRIN; BONE MORPHOGENETIC PROTEIN 4; CD71 ANTIGEN; COLLAGEN TYPE 11; COLLAGEN TYPE 5; COLLAGEN TYPE 7; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN E; DECORIN; ENDOGLIN; FIBRINOGEN; FIBROBLAST GROWTH FACTOR 6; FIBRONECTIN; HERMES ANTIGEN; LAMININ; LUMICAN; MESSENGER RNA; PHOSPHOPROTEIN; PROCOLLAGEN C PROTEINASE; STEM CELL ANTIGEN 1; STROMAL CELL DERIVED FACTOR 1; THROMBOSPONDIN 1; TRANSCRIPTION FACTOR SOX11; TRANSCRIPTION FACTOR SOX4; TRANSCRIPTION FACTOR SOX5; TRANSCRIPTION FACTOR SOX9; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL INTERACTION; DERMOEPIDERMAL JUNCTION; EPIDERMOLYSIS BULLOSA DYSTROPHICA; EXTRACELLULAR MATRIX; FIBROBLAST; GENE EXPRESSION; GENETIC TRANSCRIPTION; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SKIN CELL; TISSUE CULTURE;

EID: 78650397651     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653249.2010.518609     Document Type: Article

References (59)

1. Jackson L, Jones DR, Scotting P, Sottile V. Adult mesenchymal stem cells: differentiation potential and therapeutic applications. J Postgrad Med. 2007;53:121-7.
2. Phinney DG, Prockop DJ. Concise review. Mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair. Current views. Stem Cells. 2007;25:2896-902.
3. Chen FH, Tuan RS. Mesenchymal stem cells in arthritic diseases. Arthritis Res Ther. 2008;10:223-34.
4. Fibbe WE, Nauta AJ, Roelofs H. Modulation of immune responses by mesenchymal stem cells. Ann NY Acad Sci. 2007;1106:272-8.
5. Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol. 2002;30:42-8.
6. Djouad F, Plence P, Bony C, Tropel P, Apparailly F, Sany J, et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood. 2003;102: 3837-44.
7. Petrie Aronin CE, Tuan RS. Therapeutic potential of the immunomodulatory activities of adult mesenchymal stem cells. Birth Defects Res C Embryo Today. 2010;90:67-74.
8. Rubio D, Garcia-Castro J, Martin MC, de la Fuente R, Cigudosa JC, Lloyd AC, et al. Spontaneous human adult stem cell transformation. Cancer Res. 2005;65:3035-9.
9. Tolar J, Nauta AJ, Osborn MJ, Panoskaltsis Mortari A, McElmurry RT, Bell S, et al. Sarcoma derived from cultured mesenchymal stem cells. Stem Cells. 2007;25:371-9.
10. Rubio D, Garcia S, Paz MF, De la Cueva T, Lopez-Fernandez LA, Lloyd AC, et al. Molecular characterization of spontaneous mesenchymal stem cell transformation. PLoS One. 2008; 3:e1398.
11. Baffour R, Pakala R, Hellinga D, Joner M, Okubagzi P, Epstein SE, et al. Bone marrow-derived stem cell interactions with adult cardiomyocytes and skeletal myoblasts in vitro. Cardiovasc Revasc Med. 2006;7:222-30.
12. Bosnakovski D, Mizuno M, Kim G, Takagi S, Okumura MF, Ujinaga T. Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells (MSCs) in different hydrogels: infl uence of collagen type II extracellular matrix on MSC chondrogenesis. Biotechnol Bioeng. 2006;93:1152-63.
13. Rawadi G, Vayssiere B, Dunn F, Baron R, Roman-Roman S. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J Bone Miner Res. 2003;18:1842-53.
14. Reyes M, Dudek A, Jahagirdar B, Koodie L, Marker PH, Verfaillie CM. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest. 2002;109:337-46.
15. Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell lineage specifi cation. Cell. 2006;126: 677-89.
16. M ansilla E, Marin GH, Drago H, Sturla F, Salas E, Gardiner C, et al. Bloodstream cells phenotypically identical to human mesenchymal bone marrow stem cells circulate in large amounts under the infl uence of acute large skin damage: new evidence for their use in regenerative medicine. Transplant Proc. 2006;38:967-9.
17. Badillo AT, Redden RA, Zhang L, Doolin EJ, Liechty KW. Treatment of diabetic wounds with fetal murine mesenchymal stromal cells enhances wound closure. Cell Tissue Res. 2007;329:301-11.
18. Falanga V, Iwamoto S, Chartier M, Yufi t T, Butmarc J, Kouttab N, et al. Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fi brin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng. 2007;13:1299-312.
19. Sasaki M, Abe R, Fujita Y, Ando S, Inokuma D, Shimizu H. Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol. 2008;180:2581-7.
20. Wu Y, Chen L, Scott PG, Tredget EE. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells. 2007;25:2648-59.
21. Kim SS, Song CK, Shon SK, Lee KY, Kim CH, Lee MJ, et al. Effects of human amniotic membrane grafts combined with marrow mesenchymal stem cells on healing of fullthickness skin defects in rabbits. Cell Tissue Res. 2009;336: 59-66.
22. Walter MN, Wright KT, Fuller HR, Macneil S, Johnson WE. Mesenchymal stem cell-conditioned medium accelerates skin wound healing: an in vitro study of fi broblast and keratinocyte scratch assays. Exp Cell Res. 2010;316:1271-81.
23. Yoon BS, Moon JH, Jun EK, Kim J, Maeng I, Kim JS, et al. Secretory profi les and wound healing effects of human amniotic fl uid-derived mesenchymal stem cells. Stem Cells Dev. 2009; 19:887-902.
24. Herdrich BJ, Lind RC, Liechty KW. Multipotent adult progenitor cells: their role in wound healing and the treatment of dermal wounds. Cytotherapy. 2008;10:543-50.
25. Tolar J, Ishida-Yamamoto A, Riddle M, McElmurry RT, Osborn M, Xia L, et al. Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells. Blood. 2009;113: 1167-74.
26. Chino T, Tamai K, Yamazaki T, Otsuru S, Kikuchi Y, Nimura K, et al. Bone marrow cell transfer into fetal circulation can ameliorate genetic skin diseases by providing fi broblasts to the skin and inducing immune tolerance. Am J Pathol. 2008; 173:803-14.
27. Conget P, Rodriguez F, Kramer S, Allers C, Simon V, Palisson F, et al. Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa. Cytotherapy. 2010;12:429-31.
28. Heinonen S, Mannikko M, Klement JF, Whitaker-Menezes D, Murphy GF, Uitto J. Targeted inactivation of the type VII collagen gene (Col7a1) in mice results in severe blistering phenotype: a model for recessive dystrophic epidermolysis bullosa. J Cell Sci. 1999;112:3641-8.
29. Flagler K, Alexeev V, Pierce EA, Igoucheva O. Site-specifi c gene modifi cation by oligodeoxynucleotides in mouse bone marrow-derived mesenchymal stem cells. Gene Ther. 2008;15: 1035-48.
30. Pirrone A, Hager B, Fleckman P. Primary mouse keratinocyte culture. Methods Mol Biol. 2005;289:3-14.
31. Jeong JA, Hong SH, Gang EJ, Ahn C, Hwang SH, Yang IH, et al. Differential gene expression profi ling of human umbilical cord blood-derived mesenchymal stem cells by DNA microarray. Stem Cells. 2005;23:584-93.
32. Brittingham R, Uitto J, Fertala A. High-affi nity binding of the NC1 domain of collagen VII to laminin 5 and collagen IV. Biochem Biophys Res Commun. 2006;343:692-9.
33. Tormin A, Brune JC, Olsson E, Valcich J, Neuman U, Olofsson T, et al. Characterization of bone marrow-derived mesenchymal stromal cells (MSC) based on gene expression profi ling of functionally defi ned MSC subsets. Cytotherapy. 2009;11:114-28.
34. Dalby MJ, Andar A, Nag A, Affrossman S, Tare R, McFarlane S, et al. Genomic expression of mesenchymal stem cells to altered nanoscale topographies. J R Soc Interface. 2008;5: 1055-65.
35. Ku CH, Johnson PH, Batten P, Sarathchandra P, Chambers RC, Taylor PM, et al. Collagen synthesis by mesenchymal stem cells and aortic valve interstitial cells in response to mechanical stretch. Cardiovasc Res. 2006;71:548-56.
36. Egusa H, Iida K, Kobayashi M, Lin TY, Zhu M, Zuk PA, et al. Downregulation of extracellular matrix-related gene clusters during osteogenic differentiation of human bone marrow- and adipose tissue-derived stromal cells. Tissue Eng. 2007;13:2589-600.
37. Fan H, Liu H, Toh SL, Goh JC. Enhanced differentiation of mesenchymal stem cells co-cultured with ligament fi broblasts on gelatin/silk fi broin hybrid scaffold. Biomaterials. 2008;29: 1017-27.
38. Wang G, Bunnell BA, Painter RG, Quiniones BC, Tom S, Lanson NA Jr, et al. Adult stem cells from bone marrow stroma differentiate into airway epithelial cells: potential therapy for cystic fi brosis. Proc Natl Acad Sci USA. 2005;102: 186-91.
39. Reed CC, Iozzo RV. The role of decorin in collagen fi brillogenesis and skin homeostasis. Glycoconj J. 2002;19:249-55.
40. Kao WW, Funderburgh JL, Xia Y, Liu CY, Conrad GW. Focus on molecules: lumican. Exp Eye Res. 2006;82:3-4.
41. Strazynski M, Eble JA, Kresse H, Schonherr E. Interleukin (IL)-6 and IL-10 induce decorin mRNA in endothelial cells, but interaction with fi brillar collagen is essential for its translation. J Biol Chem. 2004;279:21266-70.
42. Yamamoto T, Eckes B, Krieg T. Effect of interleukin-10 on the gene expression of type I collagen, fi bronectin, and decorin in human skin fi broblasts: differential regulation by transforming growth factor-beta and monocyte chemoattractant protein-1. Biochem Biophys Res Commun. 2001;281:200-5.
43. Schieker M, Pautke C, Haasters F, Schieker J, Docheva D, Bocker W, et al. Human mesenchymal stem cells at the singlecell level: simultaneous seven-colour immunofl uorescence. J Anat. 2007;210:592-9.
44. Kolb M, Margetts PJ, Sime PJ, Gauldie J. Proteoglycans decorin and biglycan differentially modulate TGF-beta-mediated fi brotic responses in the lung. Am J Physiol Lung Cell Mol Physiol. 2001;280:L1327-34.
45. Mauviel A, Lapiere JC, Halcin C, Evans CH, Uitto J. Differential cytokine regulation of type I and type VII collagen gene expression in cultured human dermal fi broblasts. J Biol Chem. 1994;269:25-8.
46. Takeda H, Kon A, Ito N, Sawamura D, Takagaki K, Hashimoto I, et al. Keratinocyte-specifi c modulation of type VII collagen gene expression by pro-infl ammatory cytokines (tumor necrosis factor-alpha and interleukin-1beta). Exp Dermatol. 2005;14:289-94.
47. Shivakumar K, Sollott SJ, Sangeetha M, Sapna S, Ziman B, Wang S, et al. Paracrine effects of hypoxic fi broblast-derived factors on the MPT-ROS threshold and viability of adult rat cardiac myocytes. Am J Physiol Heart Circ Physiol. 2008; 294:H2653-8.
48. Le JM, Weinstein D, Gubler U, Vilcek J. Induction of membrane- associated interleukin 1 by tumor necrosis factor in human fi broblasts. J Immunol. 1987;138:2137-42.
49. Mauviel A, Heino J, Kahari VM, Hartmann DJ, Loyau G, Pujol JP, et al. Comparative effects of interleukin-1 and tumor necrosis factor-alpha on collagen production and corresponding procollagen mRNA levels in human dermal fi broblasts. J Invest Dermatol. 1991;96:243-9.
50. Tsutsumi S, Shimazu A, Miyazaki K, Pan H, Koike C, Yoshida E, et al. Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem Biophys Res Commun. 2001;288: 413-9. Maegawa
51. Kawamura K, Hirose M, Yajima H, Takakura Y, Ohgushi H. Enhancement of osteoblastic differentiation of mesenchymal stromal cells cultured by selective combination of bone morphogenetic protein-2 (BMP-2) and fibroblast growth factor-2 (FGF-2). J Tissue Eng Regen Med. 2007;1: 306-13.
52. Giannouli CC, Kletsas D. TGF-beta regulates differentially the proliferation of fetal and adult human skin fi broblasts via the activation of PKA and the autocrine action of FGF-2. Cell Signal. 2006;18:1417-29.
53. Kinnaird T, Stabile E, Burnett MS, Lee CW, Barr S, Fuchs S, et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res. 2004;94:678-85.
54. Forte G, Minieri M, Cossa P, Antenucci D, Sala M, Gnocchi V, et al. Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation. Stem Cells. 2006;24:23-33.
55. Bagutti C, Hutter C, Chiquet-Ehrismann R, Fassler R, Watt FM. Dermal fi broblast-derived growth factors restore the ability of beta(1) integrin-defi cient embryonal stem cells to differentiate into keratinocytes. Dev Biol. 2001;231:321-33.
56. Coraux C, Hilmi C, Rouleau M, Spadafora A, Hinnrasky J, Ortonne JP, et al. Reconstituted skin from murine embryonic stem cells. Curr Biol. 2003;13:849-53.
57. Green H, Easley K, Iuchi S. Marker succession during the development of keratinocytes from cultured human embryonic stem cells. Proc Natl Acad Sci USA. 2003;100:15625-30.
58. Iuchi S, Dabelsteen S, Easley K, Rheinwald JG, Green H. Immortalized keratinocyte lines derived from human embryonic stem cells. Proc Natl Acad Sci USA. 2006;103: 1792-7.
59. Ponte AL, Marais E, Gallay N, Langonne A, Delorme B, Herault O, et al. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells. 2007;25:1737-45.